Erschienen in:
01.08.2005 | Correspondence
The authors’ reply
verfasst von:
Anthony O’Hagan, Christopher McCabe, Ron Akehurst, Alan Brennan, Andrew Briggs, Karl Claxton, Elisabeth Fenwick, Dennis Fryback, Mark Sculpher, David Spiegelhalter, Andrew Willan
Erschienen in:
PharmacoEconomics
|
Ausgabe 8/2005
Einloggen, um Zugang zu erhalten
Excerpt
We note Dr Nuijten’s claim that “the aim of my paper was not to propose any methodologies or to give any recommendations”, but stand by our original critique of both his conceptual framework and his detailed analysis. …